AmbioPharm, Inc.

AmbioPharm was founded in 2006 and is one of the largest peptide commercial manufacturers in the world. With facilities in North Augusta (South Carolina) and Shanghai, the organization employs more than 500 chemists and industry professionals. AmbioPharm has developed a unique business model designed to handle all types of peptide manufacturing.

News from this company

News

Ambiopharm Breaks Ground on $28 Million Expansion

15.11.2024 -

Ambiopharm, a U.S.-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2)...

News

AmbioPharm Appoints Brian Gregg as CEO

04.10.2023 -

Contract development and manufacturing organization (CDMO) AmbioPharm has appointed industry veteran Brian Gregg as CEO. Gregg, who has more than 30 years of experience...

News

AmbioPharm Opens Shanghai Campus, Establishes Office in Switzerland

15.01.2021 -

AmbioPharm, a CDMO specializing in peptide active pharmaceutical ingredients (APIs), has opened its new Shanghai campus, adding nearly 50,000 square meters of...

Contact

AmbioPharm, Inc.

1024 Dittman Court
SC 29842 North Augusta
United States

+1 (803) 442-7590